4DMedical Limited (ASX:4DX)

Market Cap	2.11B +930.0%
Revenue (ttm)	5.85M +55.9%
Net Income	-30.07M
EPS	-0.14
Shares Out	572.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,782,162
Average Volume	5,721,410
Open	3.680
Previous Close	3.690
Day's Range	3.600 - 3.780
52-Week Range	0.225 - 5.420
Beta	2.78
RSI	49.98
Earnings Date	Feb 27, 2026

About 4DMedical

4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of poten...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 124
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: 4DX

Financial Performance

In fiscal year 2025, 4DMedical's revenue was 5.85 million, an increase of 55.91% compared to the previous year's 3.75 million. Losses were -30.07 million, -16.42% less than in 2024.